Journal
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume 44, Issue 12, Pages 2820-2833Publisher
WILEY
DOI: 10.1002/hed.27199
Keywords
cancer pain; cancer survivorship; epidemiology; head and neck cancer; neuropathic pain
Categories
Funding
- National Institutes of Dental and Craniofacial Research [R01 DE022891]
Ask authors/readers for more resources
This study assessed the prevalence and associated risk factors of neuropathic pain (NP) among head and neck cancer (HNC) survivors through a cross-sectional survey. The results showed that NP remained prevalent in HNC survivors, and severe pain was more common among those with NP. Age, surgery, depression, and comorbidities were identified as risk factors for NP.
Background Neuropathic pain (NP) is a debilitating symptom among head and neck cancer (HNC) survivors although few large studies report its prevalence and associated risk factors. Methods A cross-sectional survey assessing demographic, behavioral, and clinical risk factors for NP. NP was assessed using the Self-administered Leeds Assessment of Neuropathic Symptoms and Signs pain scale (S-LANSS). Results Forty-five percent (227/505) reported having pain including 13.7% (69/505) who were positive for S-LANSS. Reported pain sites were in the regions of the head and oral cavity (46.2%) and neck and throat (41.5%). Despite a higher self-reported use of analgesic medication (NP+ = 41.2%; NP- = 27.4%; p = 0.020) and alternative pain therapies (NP+ = 19.1%; NP- = 8.4%; p = 0.009), severe pain was more prevalent among those with NP (N+ = 23.2%; NP- = 13.3%; p = 0.004). Adjusted for opioid medications, ethnicity/race, age, surgery, depression, and comorbidities were risk factors for NP. Conclusion NP remains prevalent in HNC survivors highlighting the importance of routine pain surveillance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available